首页|祛风宁肺散辅助丙酸氟替卡松治疗儿童咳嗽变异性哮喘风邪犯肺证的效果

祛风宁肺散辅助丙酸氟替卡松治疗儿童咳嗽变异性哮喘风邪犯肺证的效果

扫码查看
目的:研究祛风宁肺散辅助丙酸氟替卡松治疗儿童咳嗽变异性哮喘风邪犯肺证的效果.方法:回顾性选取2021年9月—2022年9月舞钢市人民医院收治的咳嗽变异性哮喘风邪犯肺证患儿92例,根据治疗方案不同分为观察组和对照组,各46例.对照组采用丙酸氟替卡松治疗,观察组采用祛风宁肺散辅助丙酸氟替卡松治疗.比较两组临床疗效、中医证候积分、血气分析指标[动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)]、血清免疫球蛋白E(IgE)、转化生长因子-β1(TGF-β1)、可溶性程序性死亡配体 1(sPD-L1)、Toll样受体 4(TLR4)水平、不良反应发生率.结果:观察组临床总有效率为96.65%,高于对照组的80.43%(P<0.05);观察组中医证候积分低于对照组(P<0.05);观察组PaO2 高于对照组,PaCO2 低于对照组(P<0.05);观察组血清IgE、TGF-β1、TLR4水平低于对照组,sPD-L1水平高于对照组(P<0.05);观察组不良反应总发生率与对照组比较,差异无统计学意义(P>0.05).结论:祛风宁肺散辅助治疗儿童咳嗽变异性哮喘风邪犯肺证疗效显著,可有效缓解临床症状,调节血气指标,促进病情恢复,且安全可行.
Effect of Qufeng Ningfei Powder Combined with Fluticasone Propionate in the Treatment of Children with Cough Variant Asthma with Wind Pathogen Invading Lung Syndrome
Objective:To study the effect of Qufeng Ningfei powder combined with fluticasone propionate in the treatment of children with cough variant asthma with wind pathogen invading lung syndrome.Methods:A total of 92 children with cough variant asthma with wind pathogen invading lung syndrome admitted to Wugang People's Hospital from September 2021 to September 2022 were retrospectively selected and divided into observation group and control group according to different treatment schemes,with 46 cases in each group.The control group was treated with fluticasone propionate,and the observation group was treated with Qufeng Ningfei powder combined with fluticasone propionate.The clinical efficacy,TCM syndrome scores,blood gas analysis indexes[arterial partial pressure of oxygen(PaO2),arterial partial pressure of carbon dioxide(PaCO2)],serum immunoglobulin E(IgE),transforming growth factor-β1(TGF-β1),soluble programmed death ligand 1(sPD-L1),Toll-like receptor 4(TLR4)levels and incidence of adverse reactions were compared between the two groups.Results:The total clinical effective rate of the observation group was 96.65%,which was higher than 80.43%of the control group(P<0.05).The scores of TCM syndromes in the observation group were lower than those in the control group(P<0.05).PaO2 in the observation group was higher than that in the control group,and PaCO2 was lower than that in the control group(P<0.05).The levels of serum IgE,TGF-β1 and TLR4 in the observation group were lower than those in the control group,and the level of sPD-L1 was higher than that in the control group(P<0.05).There was no significant difference in the total incidence of adverse reactions between the observation group and the control group(P>0.05).Conclusion:Qufeng Ningfei powder is effective in the adjuvant treatment of children with cough variant asthma with wind pathogen invading lung syndrome,which can effectively relieve clinical symptoms,regulate blood gas indexes,and promote the recovery of the disease.It is safe and feasible.

Qufeng Ningfei powderFluticasone propionateCough variant asthmaWind pathogen invading lung syndrome

董文阁、胡营杰、付芸芸、袁斌

展开 >

舞钢市人民医院儿科,河南,舞钢 462500

河南省儿童医院中医科,河南,郑州 450000

祛风宁肺散 丙酸氟替卡松 咳嗽变异性哮喘 风邪犯肺证

2024

中国药物滥用防治杂志
中国药物滥用防治协会 军事医学科学院毒物药物研究所

中国药物滥用防治杂志

影响因子:0.584
ISSN:1006-902X
年,卷(期):2024.30(6)
  • 9